Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
Tests starting with N (3,452)
Other
Non-agency caregiver ability and willingness to assist with supervision and safety during assessment period [CMS Assessment]
Other
Non-emergency transportation attachment
Other
Non-gynecological cytology study
Other
Non-hematopoietic stem cells/Leukocytes in Body fluid by Manual count
Other
Non-hematopoietic stem cells/Leukocytes in Cerebral spinal fluid by Manual count
Other
Non-medical services attachment
Other
Non-medicare certified services offered Dialysis facility [ESRD]
Other
Non-oral vitamin D analog prescribed [ESRD]
Other
Non-regional lymph nodes examined [#] in Specimen
Other
Non-regional lymph nodes positive [#] in Specimen
Other
Non-specific active suicidal thoughts 1 month
Other
Non-specific active suicidal thoughts Lifetime
Other
Non-treponemal test was reactive [CDC.CS]
Other
Non-verbal sounds of pain in last 5 days [MDSv3]
Blood test
Nonalcoholic steatohepatitis and fibrosis panel - Serum or Plasma
Blood test
Nonalcoholic steatohepatitis grade in Serum or Plasma Qualitative
Blood test
Nonalcoholic steatohepatitis interpretation in Serum or Plasma Qualitative
Blood test
Nonalcoholic steatohepatitis score in Serum or Plasma
Blood test
Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
Other
Nonanoylcarnitine (C9) [Moles/volume] in DBS
Blood test
Nonanoylcarnitine (C9) [Moles/volume] in Serum or Plasma
Other
Nonanoylcarnitine (C9)/Creatinine [Molar ratio] in Urine
Other
Noncompliance [CCC]
Other
Noncompliance with dental treatment
Other
Noncompliance with diagnostic test [CCC]
Other
Noncompliance with dietary regimen [CCC]
Other
Noncompliance with fluid volume [CCC]
Other
Noncompliance with medication regimen [CCC]
Other
Noncompliance with safety precautions [CCC]
Other
Noncompliance with therapeutic regimen [CCC]
Other
None of above active diagnoses
Other
None of the above active diagnoses in last 7 days [MDSv3]
Other
None of the above shortness of breath symptoms in last 7 days [MDSv3]
Other
None of the above were recalled in last 7 days [MDSv3]
Other
None of the listed additional ADL patterns [Minimum Data Set]
Other
None of the listed cycle of daily events [Minimum Data Set]
Other
None of the listed diseases or conditions [Minimum Data Set]
Other
None of the listed eating patterns [Minimum Data Set]
Other
None of the listed involvement patterns [Minimum Data Set]
Other
None of the listed prior residential settings [Minimum Data Set]
Other
None of these signs of pain observed or documented in last 5 days [MDSv3]
Other
Nonessential amino acid intake 24 hour Estimated
Other
Nonessential amino acid intake 24 hour Measured
Other
Nonessential amino acid intake panel
Other
Nonhematic cells [#/volume] in Body fluid
Other
Nonhematic cells [#/volume] in Cerebral spinal fluid
Other
Nonhematic cells/Leukocytes in Body fluid
Other
Nonhematic cells/Leukocytes in Body fluid by Manual count
Other
Nonhematic cells/Leukocytes in Cerebral spinal fluid
Other
Nonhematic cells/Leukocytes in Cerebral spinal fluid by Manual count
Other
Noninfectious major illness [PhenX]
Other
Noninvasive arteriosclerosis studies panel
Other
Noninvasive arteriosclerosis study
Other
Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative
Other
Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool
Other
Noninvasive colorectal cancer RNA and occult blood screening [Presence] in Stool
Other
Noninvasive esophageal cancer DNA and esophageal cell screening [Presence] in Esophagus by Sequencing
Other
Noninvasive prenatal fetal 13 and 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
Other
Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
Other
Noninvasive prenatal fetal aneuploidy and 22q11.2 deletion panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Noninvasive prenatal fetal aneuploidy and microdeletion panel - Plasma cell-free DNA by Sequencing
Other
Noninvasive prenatal fetal aneuploidy and microdeletion panel based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific circulating cell free (ccf) DNA
Other
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free DNA
Other
Noninvasive prenatal fetal aneuploidy panel - Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA
Other
Noninvasive prenatal testing comment [Text]
Other
Noninvasive prenatal testing overall interpretation Qualitative
Other
Nonjudging score [FFMQ]
Other
Nonpharmacologic intervention for pain
Other
Nonreactivity score [FFMQ]
Other
Nonspermatozoal cells [#/area] in Semen by Microscopy high power field
Blood test
Nonsteroidal antiinflammatory drugs [Presence] in Blood by Screen method
Other
Nonsteroidal antiinflammatory drugs [Presence] in Body fluid by Screen method
Blood test
Nonsteroidal antiinflammatory drugs [Presence] in Serum or Plasma by Screen method
Other
Nonsteroidal antiinflammatory drugs [Presence] in Urine by Screen method
Other
Nonverbal pain indicators
Other
Nonverbal vocal complaints during movement
Other
Nonverbal vocal complaints while at rest
Blood test
Noonan syndrome and related conditions multigene analysis in Blood or Tissue by Molecular genetics method
Other
Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method
Blood test
Norastemizole [Mass/volume] in Serum or Plasma
Other
Norbuprenorphine [Mass/mass] in Meconium by Confirmatory method
Other
Norbuprenorphine [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Blood test
Norbuprenorphine [Mass/volume] in Serum or Plasma
Blood test
Norbuprenorphine [Mass/volume] in Serum or Plasma by Confirmatory method
Blood test
Norbuprenorphine [Mass/volume] in Serum, Plasma or Blood
Other
Norbuprenorphine [Mass/volume] in Urine
Other
Norbuprenorphine [Mass/volume] in Urine by Confirmatory method
Blood test
Norbuprenorphine [Measurement] in Serum or Plasma
Other
Norbuprenorphine [Measurement] in Urine
Other
Norbuprenorphine [Presence] in Gastric fluid by Screen method
Other
Norbuprenorphine [Presence] in Meconium
Other
Norbuprenorphine [Presence] in Saliva (oral fluid) by Confirmatory method
Blood test
Norbuprenorphine [Presence] in Serum or Plasma by Confirmatory method
Blood test
Norbuprenorphine [Presence] in Serum or Plasma by Screen method
Other
Norbuprenorphine [Presence] in Specimen by Screen method
Other
Norbuprenorphine [Presence] in Urine
Other
Norbuprenorphine [Presence] in Urine by Confirmatory method
Other
Norbuprenorphine [Presence] in Urine by Screen method
Other
Norbuprenorphine cutoff [Mass/volume] in Saliva (oral fluid) for Confirmatory method
Other
Norbuprenorphine cutoff [Mass/volume] in Urine for Confirmatory method